GB
The startup provides bioprocessing solutions that enhance the development and manufacturing of biologic therapies through advanced cell culture and purification techniques. By streamlining these processes, the company enables biopharmaceutical and contract manufacturing organizations to accelerate the delivery of safe therapies to patients.
Updated 3 months ago
Funding
$200M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup provides bioprocessing solutions that enhance the development and manufacturing of biologic therapies through advanced cell culture and purification techniques. By streamlining these processes, the company enables biopharmaceutical and contract manufacturing organizations to accelerate the delivery of safe therapies to patients.